2024 HCPCS Code J3055
Injection, talquetamab-tgvs, 0.25 mg
| Short Description | Inj talquetamab-tgvs 0.25 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Code Added Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9332 - Inj efgartigimod 2mg
- J9333 - Inj ronzanolixizum-noli 1 mg
- J9334 - Inj efgart-alfa 2mg hya-qvfc
- J9340 - Thiotepa injection
- J9345 - Inj, retifanlimab-dlwr, 1 mg
- J9347 - Inj, tremelimumab-actl, 1 mg
- J9348 - Inj. naxitamab-gqgk, 1 mg
- J9349 - Inj., tafasitamab-cxix
- J9350 - Inj mosunetuzumab-axgb, 1 mg
- J9351 - Topotecan injection
- J9352 - Injection trabectedin 0.1mg
- J9353 - Inj. margetuximab-cmkb, 5 mg
- J9354 - Inj, ado-trastuzumab emt 1mg
- J9355 - Inj trastuzumab excl biosimi
- J9356 - Inj. herceptin hylecta, 10mg
- J9357 - Valrubicin injection
- J9358 - Inj fam-trastu deru-nxki 1mg
- J9359 - Inj lon tesirin-lpyl 0.075mg
- J9360 - Vinblastine sulfate inj
- J9361 - Inj, efbemalenograstim alfa-